Latest thinking

 

Latest thinking

Brexit: impacts and actions for listed funds

22 July 2016

Listed funds need to consider the impact of the result of the Brexit referendum on their operations. This is a responsibility of both the Board and also the AIFM (if different).

Read more

Industries: Financial Institutions
Jurisdictions: United Kingdom
Services: Financial Services, Investment Funds

Latest thinking

Brexit for FinTechs

20 July 2016

Hogan Lovells has been a thought leader on the impact of FinTech since well before the referendum and has developed our Brexit Hub to keep our clients updated. In association with our strategic partners Innovate Finance, we have also been considering the impact of Brexit on the UK FinTech market.

Read more

Industries: Financial Institutions, FinTech

Latest thinking

Brexit: first aid for Pharma

19 July 2016

Brexit, if and when it happens, may have a substantial impact on the UK pharmaceutical industry. Although related issues will also have an impact upon many aspects of that industry, this note focuses on the key regulatory implications.

Read more

Industries: Life Sciences and Healthcare
Services: Administrative and Public Law, Government Relations and Policy Advocacy, Intellectual Property, Medical Device Law, Patents, Pharmaceutical and Biotechnology Regulatory Law

Latest thinking

Back to the future – but no idea when

19 July 2016

What Brexit could mean for the Anglo-European restructuring industry.

Read more

Services: Business Restructuring and Insolvency, Business Structures

Latest thinking - Macro

Possible models for the UK/EU relationship

14 July 2016

This paper summarizes some potential alternative models for the UK’s future relationship with the European Union, together with the key differences between the models which will need to be addressed in determining both the shape and impact of that new relationship.

Read more

Industries: Financial Institutions